DEN open · 2025
Adverse Events of Single Balloon Enteroscopy-assisted Endoscopic Retrograde Cholangiopancreatography in the Elderly: A Propensity Score Matching Analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nakagawa Hiroki, Takeda Tsuyoshi, Okamoto Takeshi, Mie Takafumi, Furukawa Takaaki, Sasaki Takashi, Ozaka Masato, Matsuda Takahisa, Igarashi Yoshinori, Sasahira Naoki
Аннотация
BACKGROUND: Sedation for conventional endoscopic retrograde cholangiopancreatography (ERCP) has been reported to be safe even for elderly patients. However, the safety of sedation for balloon enteroscopy-assisted ERCP (BE-ERCP) has not been well-studied in the elderly.
METHODS: We retrospectively analyzed consecutive patients with surgically altered anatomy who underwent their initial BE-ERCP using midazolam and pethidine at our institution between January 2016 and December 2022. The primary outcome was the rate of cardiopulmonary complications, including hypotension, bradycardia, tachycardia, and hypoxemia. Secondary outcomes included the rates of procedural interruptions, delayed arousal, postprocedural falls, and delirium, dose of sedatives, and rate of ERCP-related adverse events (AEs). Risk factors for cardiopulmonary complications and ERCP-related AEs were also examined.
RESULTS: A total of 190 patients were included (elderly group: 63; non-elderly group: 127). After propensity score matching, 55 patients were selected for each group. The total dose of midazolam was significantly lower in the elderly group (4 mg vs. 5 mg, p = 0.033). Rates of cardiopulmonary complication (11% vs. 11%, p > 0.999) and ERCP-related AEs (6% vs. 9%, p = 0.716) were not significantly different between the two groups. The total dose of pethidine (> 35 mg) and total procedure time (≥ 51 min) were identified as risk factors for cardiopulmonary complications and ERCP-related AEs, respectively.
CONCLUSIONS: Cardiopulmonary complications and ERCP-related AEs were similar in elderly and non-elderly patients undergoing BE-ERCP. With careful monitoring, sedation during BE-ERCP appeared safe, even for elderly patients.
METHODS: We retrospectively analyzed consecutive patients with surgically altered anatomy who underwent their initial BE-ERCP using midazolam and pethidine at our institution between January 2016 and December 2022. The primary outcome was the rate of cardiopulmonary complications, including hypotension, bradycardia, tachycardia, and hypoxemia. Secondary outcomes included the rates of procedural interruptions, delayed arousal, postprocedural falls, and delirium, dose of sedatives, and rate of ERCP-related adverse events (AEs). Risk factors for cardiopulmonary complications and ERCP-related AEs were also examined.
RESULTS: A total of 190 patients were included (elderly group: 63; non-elderly group: 127). After propensity score matching, 55 patients were selected for each group. The total dose of midazolam was significantly lower in the elderly group (4 mg vs. 5 mg, p = 0.033). Rates of cardiopulmonary complication (11% vs. 11%, p > 0.999) and ERCP-related AEs (6% vs. 9%, p = 0.716) were not significantly different between the two groups. The total dose of pethidine (> 35 mg) and total procedure time (≥ 51 min) were identified as risk factors for cardiopulmonary complications and ERCP-related AEs, respectively.
CONCLUSIONS: Cardiopulmonary complications and ERCP-related AEs were similar in elderly and non-elderly patients undergoing BE-ERCP. With careful monitoring, sedation during BE-ERCP appeared safe, even for elderly patients.